Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does minimizing neuroleptic dosage influence hyponatremia?

C M Canuso1, M B Goldman

  • 1Department of Psychiatry, University of Chicago Pritzker School of Medicine, IL 60637, USA.

Psychiatry Research
|July 31, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical antipsychotic metabolism and excretion.

Current drug metabolism·2010
Same author

Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms.

Schizophrenia research·2009
Same author

Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients.

Hippocampus·2007
Same author

Reliability of serial urine HCG as a biomarker to detect early pregnancy loss.

Human reproduction (Oxford, England)·2002
Same author

Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors.

Radiation research·2001
Same author

The silent consumer: women's reports and ratings of abortion services.

Medical care·2001

Reducing neuroleptic medication in schizophrenia patients with hyponatremia did not change serum sodium levels. Dose reduction led to behavioral relapse, indicating neuroleptic dose doesn't affect hyponatremia severity.

Area of Science:

  • Psychiatry
  • Endocrinology
  • Pharmacology

Background:

  • Hyponatremia is a common side effect of antipsychotic medications.
  • Schizophrenia patients often exhibit polydipsia, which can exacerbate hyponatremia.
  • The relationship between neuroleptic dosage and hyponatremia severity requires further investigation.

Purpose of the Study:

  • To investigate the effect of reducing neuroleptic dosage on serum sodium levels in male patients with schizophrenia and hyponatremia.
  • To determine if dose reduction impacts the severity of hyponatremia.

Main Methods:

  • A dose reduction protocol was implemented, decreasing neuroleptic medication by 10% every two weeks.
  • The study included five male patients diagnosed with schizophrenia and hyponatremia.

Related Experiment Videos

  • Serum sodium levels and behavioral relapse were monitored throughout the study period.

    • Main Results:

    • Mean neuroleptic dosage decreased significantly from 1980 +/- 1289 to 631 +/- 135 chlorpromazine equivalents/day.
    • Serum sodium levels remained stable, with no significant variation from baseline (132.9 +/- 4.9 mEq/l).
    • Behavioral relapse occurred in all patients, signifying the point at which dose reduction was no longer tolerated.

    Conclusions:

    • Minimizing neuroleptic dosage in these patients does not alter the severity of hyponatremia.
    • The findings suggest that hyponatremia in this context is not primarily driven by neuroleptic dose.
    • Further research is needed to explore alternative causes and management strategies for hyponatremia in schizophrenia.